Progressive Multiple Cranial Neuropathies as a Manifestation of CAR-T Neurotoxicity
Published online on October 25, 2025
Abstract
The Neurohospitalist, Volume 16, Issue 2, Page 233-237, April 2026.
To describe a case of delayed onset multiple cranial neuropathies as a manifestation of neurotoxicity after chimeric antigen receptor T-cell (CAR-T) therapy for multiple myeloma. While ICANS following CAR-T is a well-reported complication, it classically ...
To describe a case of delayed onset multiple cranial neuropathies as a manifestation of neurotoxicity after chimeric antigen receptor T-cell (CAR-T) therapy for multiple myeloma. While ICANS following CAR-T is a well-reported complication, it classically ...